RxDoctor Payments Data

Hatim Lukman

Obstetrics & Gynecology · Augusta, GANPI 1801901707

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Merck at 42.2% of the total. Reporting peaked in 2019 at $2,363 and has fallen 95.4% since, to $109 in 2024.

$3,400in general payments, 2019–2025

Across 72 payments — averaging $47.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
  • Novo Nordisk$1K
  • AbbVie$254
  • Astellas Pharma US Inc$196
  • Pfizer$113
  • Therapeuticsmd, Inc.$105
  • plus $284 from 13 others

What the payments were for

  • Speaking & faculty fees$1,37540%
  • Travel & lodging$522%
  • Food & beverage$1,96058%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,400 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Other obstetrics & gynecology in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →